ETC
RVMD icon

Exchange Traded Concepts’s Revolution Medicines RVMD Stock Holding History

Exchange Traded Concepts’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,255
Closed -$115K – 1488
2025
Q1 		$115K Sell
3,255
-505
-13% -$20.5K ﹤0.01% 1107
2024
Q4 		$164K Hold
3,760
– – ﹤0.01% 1033
2024
Q3 		$171K Sell
3,760
-3,037
-45% -$132K ﹤0.01% 1013
2024
Q2 		$264K Sell
6,797
-2,113
-24% -$79K 0.01% 841
2024
Q1 		$287K Sell
8,910
-2,372
-21% -$70.3K 0.01% 817
2023
Q4 		$324K Buy
11,282
+7,987
+242% +$192K 0.01% 743
2023
Q3 		$91.2K Sell
3,295
-2,262
-41% -$67.1K ﹤0.01% 933
2023
Q2 		$149K Buy
+5,557
New +$136K ﹤0.01% 844

Other funds holding RVMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Exchange Traded Concepts's RVMD Position: Q2 2025 in Review

Exchange Traded Concepts sold out of Revolution Medicines (RVMD) in Q2 2025, closing a stake of 3,255 shares — an estimated $115K sold.

Exchange Traded Concepts first reported a position in RVMD in Q2 2023 and held it in 8 quarters. The position peaked at $324K in Q4 2023. 307 funds tracked by Wall St. Rank hold RVMD as of Q2 2025.

  • Exchange Traded Concepts reported no remaining Revolution Medicines position as of Q2 2025 after selling out during the quarter.
  • Exchange Traded Concepts sold 3,255 Revolution Medicines shares in Q2 2025, an estimated $115K.
  • Exchange Traded Concepts first reported a position in Revolution Medicines in Q2 2023 and held it in 8 quarters.
  • Exchange Traded Concepts's Revolution Medicines position peaked at $324K in Q4 2023.
  • 307 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2025.

Based on Exchange Traded Concepts's 13F filing for Q2 2025, filed 10 Jul 2025.